Curcumin, the natural anticancer drug and its optimum potential is limited due to lack of
solubility in aqueous solvent, degradation at alkaline pH and poor tissue absorption. In order …

Curcumin, a yellow polyphenol derived from the turmeric Curcuma longa, has been
associated with a diverse therapeutic potential including anti‐inflammatory, antioxidant …

Introduction: Natural compounds are emerging as effective agents for the treatment of
malignant diseases. Curcumin (diferuloylmethane), the active constituent of turmeric extract …

Objective: Curcumin is extracted from Curcuma longa and regulates the intracellular signal
pathways which control the growth of cancerous cell, inflammation, invasion and apoptosis …

Comprehensive pharmacological screening of curcumin (CUR) has given the evidence that
it is an excellent naturally occurring therapeutic moiety for cancer. It is very well tolerated …

Curcumin, a yellow pigment present in turmeric, possess potential anti-proliferative and anti-
inflammatory activities but poor aqueous solubility limits its applications. In this study we …

Curcumin, a natural diphenolic compound derived from turmeric Curcuma longa, has proven
to be a modulator of intracellular signaling pathways that control cancer cell growth …

Nanoformulation of curcumin,(a low molecular weight hydrophobic drug) was prepared by
using dextran sulphate and chitosan. The developed nanoparticles were characterized by …

The polyphenol compound curcumin originates from the rhizomes of Curcuma longa Linn.
The anti-cancer effects of curcumin and its analogues are described in extensive detail and …

This study aimed to investigate the particle size effect on bioactivity, cellular internalization
and bioavailability of curcumin (CUR) nanosuspension (CUR-NS). CUR-NSs of different …